BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21349818)

  • 1. TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling.
    Li S; Bode AM; Zhu F; Liu K; Zhang J; Kim MO; Reddy K; Zykova T; Ma WY; Carper AL; Langfald AK; Dong Z
    Carcinogenesis; 2011 May; 32(5):779-85. PubMed ID: 21349818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do TRPV1 antagonists increase the risk for skin tumourigenesis? A collaborative in vitro and in vivo assessment.
    Park M; Naidoo AA; Burns A; Choi JK; Gatfield KM; Vidgeon-Hart M; Bae IH; Lee CS; Choi G; Powell AJ; Park YH; Fagg R
    Cell Biol Toxicol; 2018 Apr; 34(2):143-162. PubMed ID: 28815372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1.
    Hwang MK; Bode AM; Byun S; Song NR; Lee HJ; Lee KW; Dong Z
    Cancer Res; 2010 Sep; 70(17):6859-69. PubMed ID: 20660715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TRPV1 antagonist, PAC-14028 does not increase the risk of tumorigenesis in chemically induced mouse skin carcinogenesis.
    Choi JK; Cho W; Lee JH; Choi G; Park M
    Regul Toxicol Pharmacol; 2020 Apr; 112():104613. PubMed ID: 32044384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk.
    Moore T; Beltran L; Carbajal S; Hursting SD; DiGiovanni J
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1236-46. PubMed ID: 22896210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis.
    Bode AM; Cho YY; Zheng D; Zhu F; Ericson ME; Ma WY; Yao K; Dong Z
    Cancer Res; 2009 Feb; 69(3):905-13. PubMed ID: 19155296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
    Beider K; Rosenberg E; Dimenshtein-Voevoda V; Sirovsky Y; Vladimirsky J; Magen H; Ostrovsky O; Shimoni A; Bromberg Z; Weiss L; Peled A; Nagler A
    J Hematol Oncol; 2020 Nov; 13(1):158. PubMed ID: 33239060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transient receptor potential vanilloid-1 confers neuroprotection, reduces tumor necrosis factor-alpha, and increases IL-10 in a rat stroke model.
    Hakimizadeh E; Shamsizadeh A; Roohbakhsh A; Arababadi MK; Hajizadeh MR; Shariati M; Rahmani MR; Allahtavakoli M
    Fundam Clin Pharmacol; 2017 Aug; 31(4):420-428. PubMed ID: 28199737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice.
    Ngoc KH; Kecskés A; Kepe E; Nabi L; Keeble J; Borbély É; Helyes Z
    Eur Neuropsychopharmacol; 2023 Aug; 73():96-107. PubMed ID: 37156112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature.
    Alawi KM; Aubdool AA; Liang L; Wilde E; Vepa A; Psefteli MP; Brain SD; Keeble JE
    FASEB J; 2015 Oct; 29(10):4285-98. PubMed ID: 26136480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing-temperature water bath.
    Tékus V; Bölcskei K; Kis-Varga A; Dézsi L; Szentirmay E; Visegrády A; Horváth C; Szolcsányi J; Petho G
    Eur J Pharmacol; 2010 Sep; 641(2-3):135-41. PubMed ID: 20534382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.
    Park CK; Lü N; Xu ZZ; Liu T; Serhan CN; Ji RR
    J Neurosci; 2011 Oct; 31(42):15072-85. PubMed ID: 22016541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV3 enhances skin keratinocyte proliferation through EGFR-dependent signaling pathways.
    Wang Y; Li H; Xue C; Chen H; Xue Y; Zhao F; Zhu MX; Cao Z
    Cell Biol Toxicol; 2021 Apr; 37(2):313-330. PubMed ID: 32535744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV1 and TRPA1 in Lung Inflammation and Airway Hyperresponsiveness Induced by Fine Particulate Matter (PM
    Xu M; Zhang Y; Wang M; Zhang H; Chen Y; Adcock IM; Chung KF; Mo J; Zhang Y; Li F
    Oxid Med Cell Longev; 2019; 2019():7450151. PubMed ID: 31281589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
    Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
    Mol Pain; 2016; 12():. PubMed ID: 27178246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord.
    Kamata Y; Kambe T; Chiba T; Yamamoto K; Kawakami K; Abe K; Taguchi K
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".
    Horton JS; Shiraishi T; Alfulaij N; Small-Howard AL; Turner HC; Kurokawa T; Mori Y; Stokes AJ
    Channels (Austin); 2019 Dec; 13(1):1-16. PubMed ID: 30424709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of TRPV1 and TRPA1 in Spontaneous Pain from Inflamed Masseter Muscle.
    Wang S; Brigoli B; Lim J; Karley A; Chung MK
    Neuroscience; 2018 Aug; 384():290-299. PubMed ID: 29890293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
    Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.
    Yang H; Wang Z; Capó-Aponte JE; Zhang F; Pan Z; Reinach PS
    Exp Eye Res; 2010 Sep; 91(3):462-71. PubMed ID: 20619260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.